drugset / Trial / NCT01119157
Comparison of the Cellular and the Humoral Immunogenicity, Safety of Different Trivalent Influenza Vaccines
Phase 4
Unknown
85 enrolled
National Centre for Epidemiology, Hungary
National Public Health Institute, Finland · collabNetherlands Vaccine Institute · collab
RandomizedParallel-groupSingle-blindPrevention
Summary
This is a randomized, single-blinded, Phase IV, monocentric study in healthy adults aged \> 18 and \< 60 years to evaluate the cellular and humoral immunogenicity as well as the reactogenicity of intramuscular, inactivated, trivalent influenza vaccines, including aluminium adjuvanted whole virus vaccine, split vaccine and subunit vaccine.
Timeline
- Start
- 2008-11
- Primary completion
- 2009-03
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Influenza Virus Vaccine | Vaccine | 15 ug | Intramuscular |
Indications
No indication recorded.